What types of oncology clinical trials are available for patient referral?
We specialise exclusively in Phase 1 oncology clinical trials, focusing on early-stage studies that assess the safety, dosage, and initial effectiveness of new cancer treatments.
How can I refer a patient to your Phase 1 clinical trials?
Referrals are welcome from healthcare professionals. Please contact our clinical trials team via phone or email, or submit a referral form through our website. We will review the patient’s details and assist with eligibility screening.
How do you ensure patient safety in Phase 1 trials?
Safety is our highest priority. Phase 1 trials are conducted under strict regulatory and ethical standards, with close monitoring, frequent assessments, and multidisciplinary oversight to promptly manage any side effects or safety concerns.
Are Phase 1 trials suitable for patients with advanced or treatment-resistant cancers?
Yes. Many Phase 1 trials enrol patients who have advanced cancers or who have exhausted standard treatment options, providing access to potentially promising new therapies.
How will referring clinicians be kept informed?
We provide regular updates to the referring oncologist and GP regarding the patient’s progress, treatment response, and any clinically relevant developments. At the conclusion of the trial, care is transitioned back to the referring oncologist to ensure continuity of care.
Can’t find what you’re looking for?
If your question isn’t answered here, please fill out our enquiry form, and a member of our team will be in touch to help you directly.